Aurobindo Pharma, Ltd. Unit 01

Warning letter issued January 12, 2022 · Hyderabad, India

Inspection: Aug 2 – Aug 12, 2021
Pages: 4
FEI number: 3004021253

In short: On January 12, 2022, FDA sent a warning letter to Aurobindo Pharma, Ltd. Unit 01 in Hyderabad, Telangana (FEI 3004021253).

Inside this warning letter

The full warning letter

Every page of the warning letter, exactly as written.

Get the full warning letter

This inspection in context

The firm

Aurobindo Pharma, Ltd. Unit 01 history

All 5 documents on file for this site, in date order, with what was cited at each inspection.

Complete the picture

483
Form 483 from this inspectionAug 12, 2021$99

Aurobindo Pharma, Ltd. Unit 01 site file

All 5 documents for this site in one go: $421 instead of ~~$495~~, 15% off.

See the site history

Questions about this warning letter

When was Aurobindo Pharma, Ltd. Unit 01 inspected by FDA?

The inspection ran Aug 2 – Aug 12, 2021, and the Warning letter is dated January 12, 2022.

How do I get the full Warning letter for Aurobindo Pharma, Ltd. Unit 01?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.